| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000005344 |
| Receipt No. | R000006350 |
| Official scientific title of the study | Studies on the relationship between aspiration pneumonia and substance P in patients with ALS |
| Date of disclosure of the study information | 2011/03/30 |
| Last modified on | 2018/10/04 (Ver. 7) |
| Basic information | ||
| Official scientific title of the study | Studies on the relationship between aspiration pneumonia and substance P in patients with ALS | |
| Title of the study (Brief title) | Studies on the relationship between aspiration pneumonia and substance P in patients with ALS | |
| Region |
|
|
| Condition | ||||
| Condition | ALS | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | In order to study the difference of substance P concentrations in patients with ALS complicated with or without aspiration pneumonia. |
| Basic objectives2 | Others |
| Basic objectives -Others | In order to study the effects of substance P production and development of pneumonia in patients with ALS. |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Concentrations of substance P, bacteria in oral cavity |
| Key secondary outcomes | Vital sign, development of pneumonia |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with ALS | |||
| Key exclusion criteria | No | |||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Atsuko Ohi |
| Organization | National Hospital Organization Hachinohe National Hospital |
| Division name | Clinical Nursing Research Section |
| Address | 3-13-1 Fukiage, Hachinohe City, Aomori Prefecture, 031-0003, Japan |
| TEL | 0178-45-6111 |
| Public contact | |
| Name of contact person | Mutsuo Yamaya |
| Organization | Tohoku University Graduate School of Medicine |
| Division name | Department of Advanced Preventive Medicine for Infectious Disease |
| Address | 2-1 Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan |
| TEL | 022-717-7184 |
| Homepage URL | |
| Sponsor | |
| Institute | National Hospital Organization Hachinohe National Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | National Hospital Organization Hachinohe National Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 国立病院機構八戸病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | During the observation period, patients
who received the oral care had fewer febrile days and lower frequency of the development of pneumonia. Salivary concentration of substance P was higher in the patients received the oral care. Geriatr Gerontol Int 13: 1082-1084, 2013. |
| Other related information | During the observation period, patients
who received the oral care had fewer febrile days and lower frequency of the development of pneumonia. Salivary concentration of substance P was higher in the patients received the oral care. Geriatr Gerontol Int 13: 1082-1084, 2013. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000006350 |